1. PRODUCT SUMMARY
This advanced research formulation combines two distinct growth hormone secretagogues: CJC-1295 No DAC and Ipamorelin. CJC-1295 No DAC functions as a GHRH (Growth Hormone Releasing Hormone) analog, while Ipamorelin acts as a highly selective GHRP (Growth Hormone Releasing Peptide) receptor agonist. The blend is utilized in laboratory settings to examine the potentiation of endogenous GH pulses while maintaining baseline levels of prolactin and cortisol.
2. STORAGE & STABILITY
Lyophilized State: Store at -20°C (-4°F) for long-term stability. Protect from moisture and UV light.
Reconstituted Solution: Maintain at 2–8°C (36–46°F) post-reconstitution.
Experimental Window: For optimal results, utilize the reconstituted product within 30 days. Avoid repeated freeze-thaw cycles or excessive mechanical agitation.
3. POTENTIAL RESEARCH APPLICATIONS
Endocrine Synergy: Analyzing the intensified pituitary response via dual-pathway stimulation (GHRH + GHRP receptors).
Somatotropic Axis Mapping: Detailed studies on GH/IGF-1 signaling kinetics and feedback loops.
Metabolic & Recovery Models: Investigating the effects of enhanced GH pulses on protein synthesis and adipose tissue modulation.
Anti-Aging Research: Exploratory workflows in metabolic health and neuroendocrine biomarkers.
4. REGULATORY DISCLAIMER
NOTICE: This formulation is supplied exclusively for academic and laboratory research. It is STRICTLY NOT FOR HUMAN CONSUMPTION, nor for any therapeutic, clinical, or diagnostic use. Handling is restricted to qualified scientific professionals in controlled environments. This product is not intended to diagnose, treat, or prevent any medical condition.
Reviews
There are no reviews yet.